Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis

Friedemann Paul, Sonia Waiczies, Jens Wuerfel et al. · 2008

Read Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis by Friedemann Paul, Sonia Waiczies, Jens Wuerfel et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001928.txt.

Description

Friedemann Paul and co-authors tested a cholesterol drug at high dose in multiple sclerosis, in a 2008 PLOS ONE study. Statins calm the immune system in some settings. Data from animal models, plus a small pilot study, hinted they might help in this illness too. The drug tested was atorvastatin, given by mouth at a high dose.

The team checked safety and tolerance first, and also tracked disease activity. The drug was given alone and, for some, alongside interferon-beta, a standard therapy. Trials staged this way show whether a cheap oral drug is safe enough to test for real benefit in larger groups of patients.

Catalog record

CREATORFriedemann Paul, Sonia Waiczies, Jens Wuerfel et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001928

Browse the full library · About the Tower of Babel